INVESTINGTiny BioCryst Rides Gilead's Coattails as Biopharma Tests Similar DrugBy Scott Van VoorhisApr 29, 2020 1:06 PM EDT
PRESS RELEASESGalidesivir Stops Zika Viral Replication In Primate ModelBy GlobeNewswireJun 10, 2020 2:00 PM EDT
PRESS RELEASESBioCryst Announces Berotralstat Expanded Access Program For Patients With Hereditary Angioedema In United StatesBy GlobeNewswireJun 9, 2020 4:15 PM EDT
PRESS RELEASESHereditary Angioedema Patients Report Breakthrough Attacks On Current Injectable/Infused Prophylaxis MedicationBy GlobeNewswireJun 6, 2020 3:01 AM EDT
PRESS RELEASESBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)By GlobeNewswireJun 2, 2020 7:15 AM EDT
PRESS RELEASESBioCryst Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Completion Of Public Offering Of Common Stock And Pre-Funded WarrantsBy GlobeNewswireJun 1, 2020 4:01 PM EDT
PRESS RELEASESBioCryst To Present At Jefferies Virtual Healthcare ConferenceBy GlobeNewswireMay 28, 2020 4:15 PM EDT
PRESS RELEASESBioCryst Prices Public Offering Of Common Stock And Pre-Funded WarrantsBy GlobeNewswireMay 27, 2020 11:35 PM EDT
PRESS RELEASESBioCryst Commences Public Offering Of Common Stock And Pre-Funded WarrantsBy GlobeNewswireMay 27, 2020 4:01 PM EDT
PRESS RELEASESBioCryst Celebrates HAE Patients With HAE Global WalkBy GlobeNewswireMay 15, 2020 7:00 AM EDT
PRESS RELEASESBioCryst To Present At Upcoming Investor ConferencesBy GlobeNewswireMay 7, 2020 7:00 AM EDT
PRESS RELEASESBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)By GlobeNewswireMay 4, 2020 4:15 PM EDT
INVESTINGTiny BioCryst Rides Gilead's Coattails as Biopharma Tests Similar DrugBy Scott Van VoorhisApr 29, 2020 1:06 PM EDT
JIM CRAMERReady for a Rebound?: Cramer's 'Mad Money' Recap (Monday 4/27/20)By Scott RuttApr 27, 2020 9:50 PM EDT
PRESS RELEASESBioCryst To Report First Quarter 2020 Financial Results On May 6By GlobeNewswireApr 22, 2020 7:00 AM EDT
INVESTINGSteris Gains Emergency FDA Approval for System to Decontaminate N95 Respirators in 28 MinutesBy Dan WeilApr 10, 2020 2:08 PM EDT
PRESS RELEASESBioCryst Begins Clinical Trial With Galidesivir For Treatment Of Patients With COVID-19By GlobeNewswireApr 9, 2020 4:45 PM EDT
PRESS RELEASESBioCryst To Present At 19th Annual Needham Healthcare ConferenceBy GlobeNewswireApr 8, 2020 7:00 AM EDT
PRESS RELEASESBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)By GlobeNewswireApr 3, 2020 7:00 AM EDT
PRESS RELEASESBioCryst Appoints Anthony Doyle Chief Financial OfficerBy GlobeNewswireApr 2, 2020 7:00 AM EDT
PRESS RELEASESBEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2By GlobeNewswireMar 16, 2020 7:10 AM EDT
PRESS RELEASESBioCryst Begins Proof Of Concept Trial In PNH Patients With Oral Factor D Inhibitor, BCX9930By GlobeNewswireMar 5, 2020 7:00 AM EST
PRESS RELEASESBioCryst To Present At Barclays Global Healthcare ConferenceBy GlobeNewswireMar 3, 2020 7:00 AM EST
PRESS RELEASESBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)By GlobeNewswireMar 2, 2020 4:15 PM EST
PRESS RELEASESBioCryst To Present New Data At American Academy Of Allergy, Asthma & Immunology Annual MeetingBy GlobeNewswireFeb 27, 2020 7:00 AM EST
